Literature DB >> 27470298

Precipitous Dehydroepiandrosterone Declines Reflect Decreased Physical Vitality and Function.

Danielle N Rendina1, Carol D Ryff2, Christopher L Coe1.   

Abstract

Dehydroepiandrosterone (DHEA) and its sulfated form, DHEA-S, peak in young adulthood and then decrease dramatically with age. However, there is extensive variation in this age-related hormone decline, suggesting an early decrement may be associated with lower vitality and be prognostic of poor health in old age. To determine whether DHEA-S and DHEA are correlated with physical indices of vitality, hormone levels were analyzed with respect to clinical health histories, physical functioning including grip strength, gait speed and repetitive standing, and self-reported chronic pain. The participants (N = 1,214) were 35-86 years of age from a nationally representative survey, Midlife Development in the United States. DHEA-S and DHEA below age-expected levels were associated with more chronic illness conditions and self-reported persistent pain and pain sensitivity upon manual palpation. Additionally, lower DHEA-S and DHEA correlated with poorer performance on tests of physical functioning by middle age suggesting a more precipitous decline is already indicative of reduced vigor and physical strength. When considered with respect to age- and gender-typical norms, larger decrements in DHEA-S and DHEA may be causally related to the loss of physical vitality. Conversely, when hormone secretion is sustained in older adults, it conveys reduced risk for the physical weakness and ailments that precede frailty.
© The Author 2016. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Biomarker; Endocrinology; Frailty

Mesh:

Substances:

Year:  2017        PMID: 27470298      PMCID: PMC6074872          DOI: 10.1093/gerona/glw135

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  40 in total

1.  Dynamometer measurements of hand-grip strength predict multiple outcomes.

Authors:  R W Bohannon
Journal:  Percept Mot Skills       Date:  2001-10

Review 2.  Dehydroepiandrosterone sulphate: action and mechanism in the brain.

Authors:  Y Dong; P Zheng
Journal:  J Neuroendocrinol       Date:  2012-01       Impact factor: 3.627

3.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

4.  Persistent pain and frailty: a case for homeostenosis.

Authors:  Joseph W Shega; William Dale; Melissa Andrew; Judith Paice; Kenneth Rockwood; Debra K Weiner
Journal:  J Am Geriatr Soc       Date:  2011-12-08       Impact factor: 5.562

5.  A longitudinal study of dehydroepiandrosterone sulphate (DHEAS) change in older men and women: the Rancho Bernardo Study.

Authors:  Cara Tannenbaum; Elizabeth Barrett-Connor; Gail A Laughlin; Robert W Platt
Journal:  Eur J Endocrinol       Date:  2004-12       Impact factor: 6.664

6.  Association of decrease in serum dehydroepiandrosterone sulfate levels with the progression to type 2 diabetes in men of a Japanese population: the Funagata Study.

Authors:  Wataru Kameda; Makoto Daimon; Toshihide Oizumi; Yumi Jimbu; Minako Kimura; Akihiko Hirata; Hiroshi Yamaguchi; Hiroshi Ohnuma; Masahiko Igarashi; Makoto Tominaga; Takeo Kato
Journal:  Metabolism       Date:  2005-05       Impact factor: 8.694

7.  Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors.

Authors:  Maro R I Williams; Tye Dawood; Shanhong Ling; Aozhi Dai; Robert Lew; Kathy Myles; John W Funder; Krishnankutty Sudhir; Paul A Komesaroff
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

8.  The association between dehydroepiandosterone and frailty in older men and women.

Authors:  M Voznesensky; S Walsh; D Dauser; J Brindisi; A M Kenny
Journal:  Age Ageing       Date:  2009-03-09       Impact factor: 10.668

9.  Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty.

Authors:  Sean X Leng; Anne R Cappola; Ross E Andersen; Marc R Blackman; Kathleen Koenig; Michael Blair; Jeremy D Walston
Journal:  Aging Clin Exp Res       Date:  2004-04       Impact factor: 3.636

Review 10.  Dehydroepiandrosterone and ageing.

Authors:  Wiebke Arlt
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2004-09       Impact factor: 4.690

View more
  8 in total

Review 1.  Aging, hormones and receptors.

Authors:  M Hill; Z Třískala; P Honců; M Krejčí; J Kajzar; M Bičíková; L Ondřejíková; D Jandová; I Sterzl
Journal:  Physiol Res       Date:  2020-09-30       Impact factor: 1.881

2.  Importance of Dehydroepiandrosterone Sulfate Assessment with Special Attention for Adrenal Tumours and Arterial Hypertension.

Authors:  V Matulevicius; V Urbanavicius; S Lukosevicius; I Banisauskaite; G Donielaite; A Galkine
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 0.877

3.  Longitudinal effects of family psychopathology and stress on pubertal maturation and hormone coupling in adolescent twins.

Authors:  Jenny M Phan; Carol A Van Hulle; Elizabeth A Shirtcliff; Nicole L Schmidt; H Hill Goldsmith
Journal:  Dev Psychobiol       Date:  2020-08-30       Impact factor: 3.038

4.  Symptom Profiles, Health-Related Quality of Life, and Clinical Blood Markers among Korean Community-Dwelling Older Adults Living with Chronic Conditions.

Authors:  Jongmin Park; Nada Lukkahatai; Nancy Perrin; Yoonju Kim; Leorey N Saligan; Chang Won Won
Journal:  Int J Environ Res Public Health       Date:  2021-02-11       Impact factor: 3.390

5.  Hypothesis: Mechanisms That Prevent Recovery in Prolonged ICU Patients Also Underlie Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Authors:  Dominic Stanculescu; Lars Larsson; Jonas Bergquist
Journal:  Front Med (Lausanne)       Date:  2021-01-28

6.  Gonadotropins at Advanced Age - Perhaps They Are Not So Bad? Correlations Between Gonadotropins and Sarcopenia Indicators in Older Adults.

Authors:  Agnieszka Guligowska; Zuzanna Chrzastek; Marek Pawlikowski; Malgorzata Pigłowska; Hanna Pisarek; Katarzyna Winczyk; Tomasz Kostka
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-24       Impact factor: 5.555

Review 7.  Dehydroepiandrosterone, Cancer, and Aging.

Authors:  Arthur G Schwartz
Journal:  Aging Dis       Date:  2022-04-01       Impact factor: 6.745

8.  A pilot observational study measuring acute sarcopenia in older colorectal surgery patients.

Authors:  Carly Welch; Carolyn A Greig; Zaki K Hassan-Smith; Thomas D Pinkney; Janet M Lord; Thomas A Jackson
Journal:  BMC Res Notes       Date:  2019-01-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.